Pavel Sokolovsky

All posts

under the microscope · Sep 2022

Anti-aging drugs are being trialed in companion dogs.

The latest coverage I’ve read on the Dog Aging Project. This provides helpful context. “But dogs are just the beginning. Because they are a great model for humans, anti-aging or life-span-extending drugs that work for dogs could eventually benefit people, too.” | learn more

under the microscope · Sep 2022

An implant made from pig skin restored 19 people’s eyesight.

The research was recently published in Nature Biotechnology. This is a niche use case, relatively speaking, with around 4 million people globally thought to suffer from injured corneas. But not only is it promising for them, it’s also another demonstration of bioengineering solving real problems for people. | learn more

thoughts of food · Sep 2022

Seeking the microbial edge in hydroponic tomatoes.

“Phil’s project focuses on the root microbiome of hydroponic tomato plants. He wants to establish what’s there, how it is affected by plant management, and how it in turn contributes to plant health and productivity.” | learn more

teaching the kids · Sep 2022

Higher education can rediscover its purpose.

“These institutions have spent too much time and money building their brands and not enough educating their students.” This opinion piece published in the WSJ makes some suggestions. | learn more

uncategorized · Sep 2022

Natural gas is a fuel of the future.

An incredibly detailed write-up from Austin Vernon. “Inertia and new technology make it hard and undesirable to root out.” | learn more

big ideas · Sep 2022

New day for nuclear power?

The fuel for almost all the cutting-edge nuclear reactors is high-assay, low-enriched uranium fuel (HALEU—pronounced hey-lou). The problem is the Russian government owns the only company in the world that sells it. Yet there remains optimism in the industry thanks to continued DOE awards that signal support for domestic capacity. | learn more